Light therapy may speed C-Section wound healing
NCT ID NCT07693478
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests whether Bioptron light therapy, a type of polarized light, can improve wound healing in women who have had a cesarean section. Thirty women will receive either standard postoperative care or standard care plus daily 15-minute light sessions for five days. Researchers will measure wound size and use a healing score to compare outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bioptron light therapy (polarized polychromatic non-coherent light)
- What this could lead to
- If effective, this light therapy could speed up recovery and reduce complications after cesarean section, offering a simple, non-invasive addition to standard care.
- What could go wrong
- This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The therapy may not significantly improve healing over standard care alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 30 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Post partum women delivered by cesarean section on their first 24 hours after operation. * Their ages range from 25 to 30 years old. * Their BMI will be less than 30 kg/m2. * All females will be clinically diagnosed, confirmed and referred by the obstetricians. * They are medically stable. Exclusion Criteria: * History of any radiotherapy or chemotherapy. * History of diabetes. * History of psychological problems. * Acute infection in area treated. * Skin disease or any disease leading to delayed wound healing, such as venous or arterial disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean section; complications, wound, dehiscence are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
A specialized surgical hospital in Shebin El-kom
Menouf, Egypt